## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---
last_verified: "2026-05-30T14:51:03.143Z"
---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "SafeDosePro"
developer_entity: "eBroselow LLC"
bundle_id: "com.ebroselow.SafeDose"
app_store_id: "436443689"
google_play_id: "com.ebroselow.safedoseandroidfree"
category: "Book"
primary_platform: "ios"
primary_monetization: "Freemium"
offline_capable: false
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2025-09-27"
report_date: "2026-05-30"
last_verified: "2026-05-30"
report_version: "14.0"
total_reviews: 1058
overall_rating: 2.64
sentiment: "Mixed"
sentiment_score: 45
confidence: "low"
confidence_score: 0.7
top_praise_theme: "Accurate pediatric medication dosing calculations provide essential clinical support for emergency room medical professionals"
top_complaint_theme: "Subscription model implementation blocks access to previously purchased content and creates significant financial friction for users"
top_request_theme: "Integrated tutorial or onboarding guide to help new users navigate complex weight-based medication lookup systems"
review_sample_size: 35
total_review_count: 35
analyzed_review_count: 35
data_age_days: 0
momentum_velocity: "maintenance"
intelligence_version: 3
nemesis: "MDCalc Medical Calculator"
competitor_count: 8
tags: ["book", "freemium", "mixed sentiment", "mobile app", "app review", "app analysis", "pediatric", "emergency", "department"]
canonical_url: "https://marlvel.ai/apps/safedosepro"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

# SafeDosePro App Audit

## TL;DR {#tldr}

- **Category**: Book · Freemium
- **Signal**: Rating 2.64 · Sentiment Mixed
- **Recent focus**: Subscription model implementation blocks access to previously purchased content and creates significant financial friction for users (top complaint) · Accurate pediatric medication dosing calculations provide essential clinical support for emergency room medical professionals (top praise) · Integrated tutorial or onboarding guide to help new users navigate complex weight-based medication lookup systems (top request)

> **TL;DR:** SafeDosePro is a book app by eBroselow LLC, rated 2.64/5 by 1.1K users, with Mixed user sentiment (45/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** SafeDosePro shows Mixed sentiment (2.64/5 from 1.1K reviews) — users praise accurate pediatric medication dosing calculations provide essential clinical support for emergency room medical professionals but report issues with subscription model implementation blocks access to previously purchased content and creates significant financial friction for users.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 2.64/5 (1.1K reviews) |
| **User Mood** | Mixed |
| **Category** | Book |
| **Developer** | eBroselow LLC |
| **Pricing** | Freemium |
| **Platforms** | iOS & Android |
| **Confidence** | Low (0.7/1.0) |
| **Data Age** | 33d |

## Metadata & Market Performance
- **Publisher:** eBroselow LLC
- **Category:** Book
- **Target Audience:** Pediatric emergency department staff, nurses, pharmacists, and hospital clinical educators.
- **Platforms:** iOS & Android
- **Version Audited:** 14.0
- **Audit Date:** 2026-05-30
- **Signal Count:** 35 reviews analyzed
- **Confidence:** Low (0.7/1.0)
- **App Store ID (iOS):** 436443689
- **Bundle ID:** com.ebroselow.SafeDose
- **Google Play ID:** com.ebroselow.safedoseandroidfree
- **Performance Trend:** Declining
- **Data Window:** Analysis based on signals collected up to 2026-05-30

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** SafeDosePro is an electronic medication reference tool for pre-hospital and hospital workers, providing weight-based dosing and administration instructions on iOS and Android.
**Why users hire it:** Clinicians hire the app to eliminate manual math and reduce medication errors in high-pressure pediatric emergencies, where the single-page interface provides immediate, actionable safety checks.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Weight-based Medication Dosing:** Calculates mg, mL, and dilution requirements based on patient weight and clinical need on a single page
- **[Differentiator] SafeDose Academy:** Provides nursing CEU courses on medication safety and emergency response
  * *User Intent:* Users seek enhanced value through premium features.
- **[Differentiator] Length-based Emergency Tape:** Physical and digital reference tool for pediatric emergency resuscitation dosing
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

SafeDosePro holds a #80 Free rank in its category, but the 2.3-star Android rating against a 4.7-star iOS rating highlights a platform-specific stability gap. The discrepancy between free-tier discovery and enterprise-focused monetization creates a churn risk for individual users.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Freemium
- **Tiers:** Free public service version for individual practitioners, Enterprise hospital plans available via demo request
- **Analysis:** Freemium model uses a free mobile tool to build practitioner-level adoption, which serves as a lead generation mechanism for enterprise hospital-wide licensing.

<!-- section:sentiment -->
## 🟡 User Sentiment (Low Confidence: 35 of 35 reviews analyzed) {#user-sentiment}
- **Overall Rating:** 2.64/5
- **Platform Split:** iOS 4.7/5 (136 ratings) | Android 2.3/5 (922 ratings)
- **Overall Sentiment:** Mixed

### Top Praises
- **Accurate pediatric medication dosing calculations provide essential clinical support for emergency room medical professionals**

### Top Complaints (Impact Areas)
- **Subscription model implementation blocks access to previously purchased content and creates significant financial friction for users**

### Top Requests (What Users Want)
- **Integrated tutorial or onboarding guide to help new users navigate complex weight-based medication lookup systems**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Single-page actionable dosing interface reduces cognitive load during high-stakes pediatric emergencies
- Medically reviewed content establishes clinical authority and high switching costs for hospital systems

**Critical Frictions:**
- High-cost annual subscription model creates financial friction for individual practitioners
- Technical regressions in search functionality erode the daily clinical utility
- 0.7★ Android-iOS rating gap on majority Android base indicates poor platform parity

**Growth Levers:**
- Education partnerships untapped as B2B distribution channel for clinical educators
- Integrated onboarding tutorial could reduce churn for non-affiliated clinicians

**Market Threats:**
- Pedi STAT's specialized pediatric emergency workflow directly drains the casual-entry funnel
- MDCalc's high-velocity release cadence outpaces current stability-focused update cycles

<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

The app transitioned to a freemium model and experienced a decline in sentiment due to subscription-related access issues and new technical regressions in search.

**Overall trend**: Declining
**Compared at**: 2026-05-30

### High-impact changes
- **[Shifted] Monetization Model** (pricing) — Shifted from a subscription-only model to a freemium model with a free public service tier and enterprise licensing.
- **[Declined] User Sentiment and Complaints** (sentiment) — Sentiment shifted to mixed; new top complaints include loss of access to previously purchased content and high-cost subscription friction.
- **[Added] Technical Regressions** (swot) — Added search functionality regressions as a primary weakness and driver of negative sentiment.

### Medium-impact changes
- **[Improved] Feature Competitive Position** (features) — Repositioned core features (Weight-based Dosing, SafeDose Academy, Emergency Tape) from 'standard' to 'differentiator'.
- **[Shifted] Target Audience Expansion** (audience) — Refined target audience from general practitioners to a more specific set including pediatric emergency staff, nurses, pharmacists, and clinical educators.

<!-- section:rivals -->
## Rivals Landscape {#rivals}

> Competitive positioning identified by AI analysis of app features, category, and market signals.

### SafeDosePro vs MDCalc Medical Calculator — Head to Head
- **[MDCalc Medical Calculator](https://marlvel.ai/apps/mdcalc-medical-calculator)** by MD Aware, LLC: Dominates the clinical decision support space with a massive user base and high-frequency updates that directly overlap with SafeDose's medication calculation utility.
  - **Moat strength:** High — sustainable advantage over 12 months
  - **Key differences:**
    - Provides a comprehensive library of thousands of clinical calculators beyond just medication dosing.
    - Maintains a high-velocity release cadence with three updates in the last six months.
    - Offers a platform-agnostic web and mobile experience that captures users across all clinical settings.
  - **Where SafeDosePro wins:**
    - ✅ Focuses exclusively on a single-page actionable view for medication administration, reducing cognitive load for emergency responders.
    - ✅ Provides specialized mixing and dilution instructions that are often buried in general-purpose medical calculators.
  - **Where MDCalc Medical Calculator wins:**
    - ❌ Offers a massive, peer-reviewed library of clinical decision tools that creates a high barrier to entry.
    - ❌ Maintains a superior cross-platform UX that keeps users within their ecosystem for all clinical needs.
  - **Verdict:** SafeDose must double down on its 'single-page' emergency workflow to differentiate from MDCalc's broad, multi-step calculator library.

### Contenders (Strong Challengers)
- **[Nursing Central](https://marlvel.ai/apps/com-unboundmedicine-nursingcentral)** by Unbound Medicine, Inc. [Moat: Medium]: A highly specialized, frequently updated resource that captures the nursing demographic with deep clinical content.
  - Integrates comprehensive drug guides with disease and test information specifically tailored for nursing workflows.
  - Maintains an aggressive release schedule with six updates in the last six months, ensuring high content freshness.
- **[DynaMed](https://marlvel.ai/apps/dynamed)** by EBSCO Publishing [Moat: Medium]: Provides evidence-based clinical information that serves as a primary reference for hospital-based medical professionals.
  - Delivers rigorous, evidence-based clinical summaries that are trusted for high-stakes hospital decision-making.
  - Leverages the massive EBSCO distribution network to maintain a strong foothold in institutional medical settings.

### Peers (What They Do Better)
- **[UpToDate](https://marlvel.ai/apps/uptodate)** by UpToDate, Inc.: The industry standard for clinical reference, though it serves a broader diagnostic purpose than SafeDose's specific dosing focus.
  - Acts as the definitive clinical knowledge base for physicians, creating a massive content-based competitive moat.
  - Requires institutional subscriptions, which limits its accessibility compared to SafeDose's public service model.
- **[Calculate by QxMD](https://marlvel.ai/apps/calculate-by-qxmd)** by WebMD: A direct competitor in the clinical calculator space with a strong brand presence under the WebMD umbrella.
  - Integrates seamlessly with electronic health records, providing a workflow advantage for hospital-based clinicians.
  - Utilizes a broad, multi-specialty approach that covers more clinical ground than SafeDose's medication-specific focus.
- **[Merck Manual Professional](https://marlvel.ai/apps/merck-manual-professional)** by Merck & Co Inc: Provides authoritative medical information that acts as a trusted reference for professionals, though less focused on rapid dosing.
  - Offers a highly credible, peer-reviewed medical reference library that is free from commercial influence.
  - Focuses on comprehensive clinical knowledge rather than the rapid, actionable dosing workflows of SafeDose.
- **[Micromedex](https://marlvel.ai/apps/micromedex)** by Merative: A specialized drug information resource that competes directly with SafeDose's medication administration utility.
  - Provides deep, clinical-grade pharmacological data that is essential for hospital pharmacy and nursing workflows.
  - Focuses on drug-specific safety and interaction data rather than the pre-hospital emergency dosing focus of SafeDose.

### New Kids on the Block (What's Innovative)
- **[Pedi STAT](https://marlvel.ai/apps/com-qxmd-pedsguide)** by James M Kempema MD PA: A niche, specialized tool for pediatric emergency dosing that directly challenges SafeDose's core value proposition.

<!-- /section:rivals -->
<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Integrated SafeDose Academy CEU courses.
- Launched next-generation pediatric emergency tape.

> **Cadence:** 5 total versions · 0 majors in last 6 months · 204 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

SafeDosePro is an established book app that is free with in-app purchases.
With a 2.64/5 rating from 1.1K reviews, it shows polarized user reception.

<!-- speakable-start -->
> **Bottom Line:** SafeDosePro maintains a strong clinical moat through its specialized pediatric dosing workflow, but the recent subscription shift and search regressions are driving away core users, so the PM must prioritize stability and access transparency to protect the enterprise funnel.
<!-- speakable-end -->

**Best for:** Pediatric emergency department staff, nurses, pharmacists, and hospital clinical educators.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] [HIGH IMPACT] Rebuild search functionality because broken lookups are the #1 technical complaint → recover professional sentiment — *Search regressions are cited as a primary reason for recent negative reviews.* _(trade-off: deprioritize Push the SafeDose Academy UI refresh to Q4 — search stability has higher impact on daily clinical retention.)_
- [ ] [PIVOT] [HIGH IMPACT] Audit subscription paywall logic because users report losing previously purchased content → reduce churn — *Loss of access to previously paid content is the top complaint theme.* _(trade-off: deprioritize Pause the new CEU course development — fixing trust issues is a prerequisite for revenue growth.)_
<!-- /section:pm-actions -->

<!-- section:feature-gaps -->
### Feature Gaps vs Competitors

- EHR integration (available in Calculate by QxMD but absent here)
- Multi-specialty calculator library (available in MDCalc but absent here)
<!-- /section:feature-gaps -->

<!-- section:outlook -->
### Outlook: Declining

The clinical reference market is consolidating around high-velocity, multi-purpose tools that offer better platform stability. SafeDosePro's current maintenance-mode updates leave it exposed to specialized rivals like Pedi STAT, which will erode the user base unless search stability is restored immediately.

- 🔴 Technical regressions in search functionality (broken listings) erode the daily clinical habit, which compounds the rating drag already visible on Android.
- 🔴 The transition to a high-cost annual subscription blocks access to legacy content, accelerating churn pressure on the individual practitioner base into Q1.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 2.64/5 |
| Total Reviews | 1.1K |
| Sentiment | Mixed (45/100) |
| Confidence | Low |
| Pricing Model | Freemium |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Trend | Declining |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **SafeDosePro** (this app) | 2.64/5 | Mixed | eBroselow LLC |
| [Pedi STAT](https://marlvel.ai/apps/com-qxmd-pedsguide) | 4.5/5 | N/A | James M Kempema MD PA |
| [Nursing Central](https://marlvel.ai/apps/com-unboundmedicine-nursingcentral) | 4.9/5 | N/A | Unbound Medicine, Inc. |
| [UpToDate](https://marlvel.ai/apps/uptodate) | 4.3/5 | N/A | UpToDate, Inc. |
| [MDCalc Medical Calculator](https://marlvel.ai/apps/mdcalc-medical-calculator) | 4.9/5 | N/A | MD Aware, LLC |
| [Merck Manual Professional](https://marlvel.ai/apps/merck-manual-professional) | 4.8/5 | N/A | Merck & Co Inc |

## Company Profile
- **Developer:** eBroselow LLC
- **Website:** [https://www.ebroselow.com/](https://www.ebroselow.com/)
- **Social:** [Instagram](https://www.instagram.com/safedoseinc) · [Facebook](https://www.facebook.com/safedoseinc) · [LinkedIn](https://www.linkedin.com/company/safedose)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/safedosepro/id436443689?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.ebroselow.safedoseandroidfree&hl=en&gl=us)
- **Dev Site:** [Official Website](https://www.ebroselow.com/)
- **Sources:** Developer website content, About us / company information, App store metadata, User reviews.

## Related Intel Reports
- [*Pedi STAT*](https://marlvel.ai/apps/com-qxmd-pedsguide) (James M Kempema MD PA) — 4.5/5 Rating | N/A Sentiment
- [*Nursing Central*](https://marlvel.ai/apps/com-unboundmedicine-nursingcentral) (Unbound Medicine, Inc.) — 4.9/5 Rating | N/A Sentiment
- [*UpToDate*](https://marlvel.ai/apps/uptodate) (UpToDate, Inc.) — 4.3/5 Rating | N/A Sentiment
- [*MDCalc Medical Calculator*](https://marlvel.ai/apps/mdcalc-medical-calculator) (MD Aware, LLC) — 4.9/5 Rating | N/A Sentiment
- [*Merck Manual Professional*](https://marlvel.ai/apps/merck-manual-professional) (Merck & Co Inc) — 4.8/5 Rating | N/A Sentiment
- [*Calculate by QxMD*](https://marlvel.ai/apps/calculate-by-qxmd) (WebMD) — 4.8/5 Rating | N/A Sentiment
- [*DynaMed*](https://marlvel.ai/apps/dynamed) (EBSCO Publishing) — 4.9/5 Rating | N/A Sentiment
- [*Micromedex*](https://marlvel.ai/apps/micromedex) (Merative) — 3.8/5 Rating | N/A Sentiment
- [*Gutenberg | eBook Reader*](https://marlvel.ai/apps/gutenberg-ebook-reader) (Webron Software LTD) — 4.4/5 Rating | N/A Sentiment
- [*كتبي للجميع*](https://marlvel.ai/apps/app--163) (Ahmed Emad AlDeen Lotfy Mahmoud) — N/A Rating | N/A Sentiment

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting.
4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.7/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 35
- **Data Sources:** user reviews, developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 33 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/safedosepro)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.